• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.

EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014 May; 35(5):1100-9.

View in: PubMed

subject areas
  • Animals
  • Antineoplastic Agents
  • Apoptosis
  • Cell Line
  • Cell Survival
  • Cisplatin
  • Disease Models, Animal
  • Drug Resistance, Neoplasm
  • Female
  • Gene Expression
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Humans
  • Mice
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Neoplasms, Glandular and Epithelial
  • Ovarian Neoplasms
  • Proteolysis
  • Transcription, Genetic
  • Ubiquitin-Protein Ligases
  • Xenograft Model Antitumor Assays

authors with profiles
  • Joe B Blumer
  • Scott T. Eblen